News and Commentary

AMCP To Test New Guidelines For Formularies


The Academy of Managed Care Pharmacy thinks there's a better way for health plans and pharmacy benefit managers to make formulary decisions than by simply looking at line-item budget figures.

AMCP will test a set of guidelines for pharmacy and therapeutics committees to follow when adding or removing products from formularies. Intending its guidelines to "rationalize" decision making, AMCP will study the effect of formulary decisions on outcomes for given populations. The guidelines also are meant to assist drug manufacturers in producing economic data that are useful to P&T committees.

The standards are modeled on submission guidelines used at Seattle's Regence Blue Shield.

Now available

Precision medicine, big data, Alzheimer’s Disease, migraine, and RNA therapeutics.
Learnings from the April 2018 meeting.
Edited by Jill Condello, PhD, ICON Access, Commercialisation & Communications